Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
1998-11-16
pubmed:abstractText
The G1-S transition in mammalian cells has been demonstrated to require the cyclin-dependent kinases cdk2, cdk3 and cdk4/6. Here we show that a novel kinase activity associated with cdk3 fluctuates throughout the cell cycle differently from the expression of cyclin D1-, E- and A-associated kinase activities. Cdk3 kinase activity is neither affected by p16 (in contrast to cdk4/6) nor by E2F-1 (in contrast to cdk2), but is downregulated upon transient p27 expression. We found cdk3 to bind to p21 and p27. We provide evidence that p27 could be involved in the regulation of the cell cycle fluctuation of cdk3 activity: cdk3 protein does not fluctuate and interaction of cdk3 with p27, but not with p21, is lost when cdk3 kinase becomes active during the cell cycle. In Myc-overexpressing cells, but not in normal Ratl cells, constitutive ectopic expression of cdk3 induces specific upregulation of cdk3-associated kinase activity that is still cell cycle phase dependent. Ectopic cdk3, but not cdk2, enhances Myc-induced proliferation and anchorage-independent growth associated with Myc activation, without effects on cyclin D1, E and A protein expression or kinase activities. High levels of cdk3 in Myc-overexpressing cells trigger up- and deregulation of E2F-dependent transcription without inducing the E2F-DNA binding capacity. In contrast to all other studied positive G regulators, cdk3 is unable to cooperate with ras in fibroblast transformation suggesting a function of cdk3 in G1 progression that is different from cyclin D- or E-associated kinase activities. Our data provide first insights into the regulation of cdk3-associated kinase activity and suggest a model how cdk3 participates in the regulation of the G1-S transition.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/4-hydroxytamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/CDC2-CDC28 Kinases, http://linkedlifedata.com/resource/pubmed/chemical/CDK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CDK3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cdk2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1a protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1b protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2259-69
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:9811456-Animals, pubmed-meshheading:9811456-CDC2-CDC28 Kinases, pubmed-meshheading:9811456-Cell Adhesion, pubmed-meshheading:9811456-Cell Cycle, pubmed-meshheading:9811456-Cell Cycle Proteins, pubmed-meshheading:9811456-Cell Division, pubmed-meshheading:9811456-Cell Transformation, Neoplastic, pubmed-meshheading:9811456-Cyclin-Dependent Kinase 2, pubmed-meshheading:9811456-Cyclin-Dependent Kinase 3, pubmed-meshheading:9811456-Cyclin-Dependent Kinase Inhibitor p16, pubmed-meshheading:9811456-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:9811456-Cyclin-Dependent Kinase Inhibitor p27, pubmed-meshheading:9811456-Cyclin-Dependent Kinases, pubmed-meshheading:9811456-Cyclins, pubmed-meshheading:9811456-Down-Regulation, pubmed-meshheading:9811456-Enzyme Induction, pubmed-meshheading:9811456-Genetic Vectors, pubmed-meshheading:9811456-Humans, pubmed-meshheading:9811456-Microtubule-Associated Proteins, pubmed-meshheading:9811456-Protein-Serine-Threonine Kinases, pubmed-meshheading:9811456-Proto-Oncogene Proteins c-myc, pubmed-meshheading:9811456-Rats, pubmed-meshheading:9811456-Tamoxifen, pubmed-meshheading:9811456-Tumor Suppressor Proteins
pubmed:year
1998
pubmed:articleTitle
Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
pubmed:affiliation
Obstetrics and Gynecology, University of Vienna, Department of Prenatal Diagnosis and Therapy, Austria.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't